UCB (MEX:UCBN) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


MEX:UCBN UCB SA MEX:UCBN
85 GF Score
Price MXN1,692.27
GF Value MXN1,417.06
! 2 Warning Signs
View Full Analysis

What is UCB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

UCB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

MEX:UCBN vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, UCB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

UCB Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, UCB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where UCB's Margin of Safety % (DCF FCF Based) falls into.


MEX:UCBN
85GF Score
UCB SA MEX:UCBN
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is UCB (MEX:UCBN) Overvalued in 2026?

Based on GuruFocus' analysis, UCB stock appears to be overvalued. The current stock price of MXN1,692.27 is trading 19.4% above its estimated GF Value™ of MXN1,417.06.

Key valuation signals for MEX:UCBN:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: MXN1,417.06 vs. price of MXN1,692.27 (19.4% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the MEX:UCBN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UCB Business Description

Address Allee de la Recherche, 60, Brussels, BEL, B-1070
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome), and Kygevvi (rare mitochondrial disease).
85GF Score

Get the complete analysis for MEX:UCBN

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,692.27
Price
MXN1,417.06
GF Value